Morgan Stanley’s DermTech, Inc. Common Stock DMTK Stock Holding History
Bought
Maintained
Sold
Other funds holding DMTK
PA
GWSA
T2I
Morgan Stanley's DMTK Position: Q2 2024 in Review
Morgan Stanley sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 96,149 shares — an estimated $67.5K sold.
Morgan Stanley first reported a position in DMTK in Q4 2017 and held it in 20 quarters. The position peaked at $7.55M in Q2 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.
- Morgan Stanley reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Morgan Stanley sold 96,149 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $67.5K.
- Morgan Stanley first reported a position in DermTech, Inc. Common Stock in Q4 2017 and held it in 20 quarters.
- Morgan Stanley's DermTech, Inc. Common Stock position peaked at $7.55M in Q2 2021.
- 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.
Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.